Hims & Hers Health (HIMS) Change in Acquisitions & Divestments (2020 - 2026)
Hims & Hers Health's (HIMS) quarterly Change in Acquisitions & Divestments came in at $76.7 million in Q1 2026, up 205.43% quarter-over-quarter from -$72.8 million in Q4 2025.
Hims & Hers Health (HIMS) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Change in Acquisitions & Divestments across 7 years of filings, most recently posting $76.7 million for Q1 2026.
- Change in Acquisitions & Divestments for Q1 2026 came in at $76.7 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $76.7 million (up 179.1% YoY), and the FY2024 annual result was $725000.0, down 53.94% from the prior year.
- Change in Acquisitions & Divestments came in at $76.7 million for Q1 2026 at Hims & Hers Health, up from -$72.8 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $97.7 million in Q1 2024 to a low of -$188.6 million in Q4 2024.
- The 5-year median for Change in Acquisitions & Divestments is $33.4 million (2022), against an average of $7.2 million.
- Across the five-year window, Change in Acquisitions & Divestments soared 174.52% in 2022 and tumbled 80.71% in 2025, its largest moves.
- Hims & Hers Health's Change in Acquisitions & Divestments stood at -$98.9 million in 2022, then declined by 17.03% to -$115.8 million in 2023, then sank by 62.89% to -$188.6 million in 2024, then surged by 61.42% to -$72.8 million in 2025, then surged by 205.43% to $76.7 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $76.7 million (Q1 2026), -$72.8 million (Q4 2025), and $12.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.71 Mn |
| Mar 31, 2026 | 76.71 Mn |
| Dec 31, 2025 | -72.76 Mn |
| Dec 31, 2025 | -72.76 Mn |
| Sep 30, 2025 | 12.19 Mn |
| Sep 30, 2025 | 12.19 Mn |
| Jun 30, 2025 | 60.57 Mn |
| Jun 30, 2025 | 60.57 Mn |
| Dec 31, 2024 | -188.57 Mn |
| Dec 31, 2024 | -188.57 Mn |
| Sep 30, 2024 | 63.20 Mn |
| Sep 30, 2024 | 63.20 Mn |
| Jun 30, 2024 | 28.40 Mn |
| Jun 30, 2024 | 28.40 Mn |
| Mar 31, 2024 | 97.70 Mn |
| Mar 31, 2024 | 97.70 Mn |
| Dec 31, 2023 | -115.76 Mn |
| Dec 31, 2023 | -115.76 Mn |
| Sep 30, 2023 | 45.00 Mn |
| Sep 30, 2023 | 45.00 Mn |